endometrial cancer

GSK's Jemperli prolongs life in endometrial cancer trial. Will FDA label expansion come next?
GSK's Jemperli prolongs life in endometrial cancer trial. Will FDA label expansion come next?
Fierce Pharma
GSK
Jemperli
endometrial cancer
clinical trials
Flag link:
ESMO: AstraZeneca proposes adding Lynparza to Imfinzi as endometrial cancer race heats up
ESMO: AstraZeneca proposes adding Lynparza to Imfinzi as endometrial cancer race heats up
Fierce Pharma
ESMO
AstraZeneca
Merck
Lynparza
endometrial cancer
Flag link:
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
Fierce Pharma
GSK
FDA
immunotherapy
endometrial cancer
Jemperli
Flag link:
AstraZeneca reports positive results from endometrial cancer therapy trial
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
AstraZeneca
endometrial cancer
clinical trials
Imfinzi
Lynparza
Flag link:
AstraZeneca's drug combo shows positive results in late-stage cancer trial
AstraZeneca's drug combo shows positive results in late-stage cancer trial
Reuters
ASCO 2023
AstraZeneca
Imfinzi
Lynparza
endometrial cancer
Flag link:
Merck Eyes Third Endometrial Cancer Nod for Keytruda
Merck Eyes Third Endometrial Cancer Nod for Keytruda
BioSpace
Merck
Keyruda
clinical trials
endometrial cancer
Flag link:
GSK Notches Phase III Win for Jemperli in Endometrial Cancer
GSK Notches Phase III Win for Jemperli in Endometrial Cancer
BioSpace
GSK
Jemperli
clinical trials
endometrial cancer
Flag link:
A startup plans an IPO to give a shelved Lilly drug another shot
A startup plans an IPO to give a shelved Lilly drug another shot
BioPharma Dive
Acrivon Therapeutics
IPOs
Eli Lilly
prexasertib
ovarian cancer
endometrial cancer
bladder cancer
precision medicine
Flag link:
Could This FDA Approval Be a Boost for Merck?
Could This FDA Approval Be a Boost for Merck?
Motley Fool
Merck
Keytruda
FDA
endometrial cancer
Flag link:
FDA approves Merck’s anti-PD-1 therapy for endometrial carcinoma patients
FDA approves Merck’s anti-PD-1 therapy for endometrial carcinoma patients
Pharmaceutical Business Review
Merck
Keytruda
endometrial cancer
FDA
Flag link:
Merck, Eisai notch full approval for Keytruda-TKI inhibitor combo in advanced endometrial cancer
Merck, Eisai notch full approval for Keytruda-TKI inhibitor combo in advanced endometrial cancer
Endpoints
Merck
Keytruda
Lenvima
endometrial cancer
FDA
Flag link:
FDA approves GSK drug for endometrial cancer with specific genetic signature
FDA approves GSK drug for endometrial cancer with specific genetic signature
MedCity News
GSK
Jemperli
dostarlimab
FDA
endometrial cancer
Flag link:
Merck breathes a sigh of relief as Keytruda-Lenvima combo aces confirmatory study in endometrial cancer
Merck breathes a sigh of relief as Keytruda-Lenvima combo aces confirmatory study in endometrial cancer
Endpoints
Merck
FDA
Keytruda
Eisai
Lenvima
clinical trials
endometrial cancer
Flag link:
Glaxo joins the Covid-19 delay queue
Glaxo joins the Covid-19 delay queue
EP Vantage
GSK
dostarlimab
COVID-19
FDA
pandemic
endometrial cancer
Flag link:
GSK posts middling data from PD-1 Tesaro buyout drug
GSK posts middling data from PD-1 Tesaro buyout drug
Fierce Biotech
GSK
Tesaro
dostarlimab
clinical trials
endometrial cancer
Flag link:
ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK
ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK
Fierce Pharma
Merck
Eisai
Keytruda
Lenvima
endometrial cancer
ESMO
Flag link:
Merck, Eisai's Keytruda-Lenvima combo wins simultaneous OKs in U.S., Canada and Australia
Merck, Eisai's Keytruda-Lenvima combo wins simultaneous OKs in U.S., Canada and Australia
Fierce Pharma
Merck
Keytruda
Eisai
Lenvima
endometrial cancer
Canada
Australia
Flag link:
Will GSK/Tesaro’s Checkpoint Inhibitor Be Able to Compete With Merck’s Keytruda?
Will GSK/Tesaro’s Checkpoint Inhibitor Be Able to Compete With Merck’s Keytruda?
BioSpace
GSK
Tesaro
Merck
Keytruda
endometrial cancer
dostarlimab
Flag link:
Endometrial Cancer Drug Fails in Late-Stage Clinical Trial
Endometrial Cancer Drug Fails in Late-Stage Clinical Trial
Xtalks
endometrial cancer
Aeterna Zentaris
clinical trials
Zoptrex
Flag link:
Aeterna Zentaris shares eviscerated by its latest late-stage drug disaster
Aeterna Zentaris shares eviscerated by its latest late-stage drug disaster
Endpoints
Aeterna Zentaris
clinical trials
Zoptrex
endometrial cancer
Flag link:

Pages